Belfiore F, Rabuazzo A M, Iannello S, Campione R, Vasta D
Biochem Med Metab Biol. 1986 Apr;35(2):149-55. doi: 10.1016/0885-4505(86)90069-1.
In contrast to liver, adipose tissue, and muscle, in which the diabetic state is associated with a "catabolic response," some tissues, typically the kidney and perhaps the intestinal mucosa and some vascular cell types, show an "anabolic response" to diabetes, with enhanced activity of the anabolic pathways and diminished activity of the catabolic ones. The kidney of alloxan or streptozotocin diabetic rats is hypertrophied, and shows enrichment in intracellular glycogen and abundant accumulation of glycoprotein material at the basement membrane level. Accordingly, protein synthesis and the enzymes of glucose utilization as well as those engaged in UDP sugar formation or in the hydroxylation and glycosylation processes (required for glycoprotein synthesis) show increased activity in the diabetic kidney, while the catabolic, lysosomal enzymes (cathepsin D and several glycosidases) are depressed. We observed a reduction of -24% in the activity of cathepsin D and -23% in that of galactosidase in the kidney of streptozotocin diabetic mice, as opposed to increases of +135 and +32%, respectively, found in liver. It is not known which factor(s) may be responsible for such an anabolic response of some tissues to diabetes, but persistent hyperglycemia and/or some hormonal abnormalities may be involved. The above data refer to changes in tissue enzyme content caused by induction-repression mechanisms, but rapid (activation-inhibition) effects may also occur. We observed that preincubation of slices of mouse kidney cortex for 10 min with 20.8 mmole/liter glucose resulted in a 80% activation of phosphofructokinase, as assayed in the tissue homogenate at physiological (50 mumole/liter) concentration of the substrate fructose-6-P, suggesting that hyperglycemia may be responsible for some of the metabolic changes occurring in the diabetic kidney.
与肝脏、脂肪组织和肌肉不同,在这些组织中糖尿病状态与“分解代谢反应”相关,而一些组织,尤其是肾脏,可能还有肠黏膜和某些血管细胞类型,对糖尿病呈现“合成代谢反应”,合成代谢途径的活性增强,分解代谢途径的活性减弱。用四氧嘧啶或链脲佐菌素诱导的糖尿病大鼠的肾脏会肥大,并且在细胞内糖原含量增加,在基底膜水平有丰富的糖蛋白物质积累。相应地,蛋白质合成、葡萄糖利用酶以及参与UDP糖形成或羟基化和糖基化过程(糖蛋白合成所必需)的酶在糖尿病肾脏中的活性增加,而分解代谢的溶酶体酶(组织蛋白酶D和几种糖苷酶)活性降低。我们观察到,链脲佐菌素诱导的糖尿病小鼠肾脏中组织蛋白酶D的活性降低了24%,半乳糖苷酶的活性降低了23%,而在肝脏中分别增加了135%和32%。尚不清楚哪些因素可能导致某些组织对糖尿病产生这种合成代谢反应,但持续性高血糖和/或某些激素异常可能与之有关。上述数据指的是由诱导-抑制机制引起的组织酶含量变化,但也可能发生快速(激活-抑制)效应。我们观察到,将小鼠肾皮质切片在20.8毫摩尔/升葡萄糖中预孵育10分钟后,在底物果糖-6-磷酸生理浓度(50微摩尔/升)下测定组织匀浆中的磷酸果糖激酶活性,结果显示其活性激活了80%,这表明高血糖可能是糖尿病肾脏中发生的一些代谢变化的原因。